Joshua Muia, PhD

Publications

• The absence of ADAMTS13 improves early outcomes in an experimental model of trauma with uncontrolled hemorrhage.

  (Sloos PH, Vermeersch L, Hameed R, Maas MAW, Delmote AS, Roelofs JJTH, Muia J, Tersteeg C, Vanhoorelbeke K, Juffermans NP, Kleinveld DJB.) J Trauma Acute Care Surg. 2026 Oct 01;101(4):689-698 PMID: 42425696 PMCID: PMC13619138 SCOPUS ID: 2-s2.0-105047141838 07/10/2026

• Promoting diversity, equity, and inclusion in ISTH committee structures: how well are we doing?

  (Douketis JD, Toscano MN, Constantin B, Khanna S, Muia J, Nagao A, Reis Nóbrega TD, Orsi FA, Scarlatescu E.) J Thromb Haemost. 2026 Sep 02 PMID: 42686066 SCOPUS ID: 2-s2.0-105052910588 09/03/2026

• The biology and pathophysiology of the proatherogenic metalloprotease ADAMTS7.

  (Goyal S, Muniu J, Bhat MA, Oldham E, Pruitt DW, Frias Perez L, Miranda FZ, Muia J.) Open Biol. 2026 Apr 01;16(4) PMID: 41920022 PMCID: PMC13673249 SCOPUS ID: 2-s2.0-105034818167 04/01/2026

• A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock☆.

  (Sloos PH, Vermeersch L, Roozendaal DS, Delmote AS, Veer CV', Momanyi TO, Miranda FZ, Muia J, Tersteeg C, Vanhoorelbeke K, Juffermans NP, Kleinveld DJB.) Br J Anaesth. 2026 Jan;136(1):107-116 PMID: 41058374 PMCID: PMC13269631 SCOPUS ID: 2-s2.0-105018014055 10/08/2025

• Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood Cells.

  (Roberts KS, Zhang S, Batbayar K, Yan Z, Muia J, Mulvey JJ, Olivier E, Pullman JM, Cataland SR, Bouhassira EE.) bioRxiv. 2025 Jun 15 PMID: 40661424 PMCID: PMC12259171 07/15/2025

• Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity.

  (Liu S, Ma M, Qu J, Muia J, Wu Z, Bonnez Q, Vanhoorelbeke K, Zheng L, Zhao X, Zheng XL.) Arterioscler Thromb Vasc Biol. 2025 Apr;45(4):506-522 PMID: 39945068 PMCID: PMC11945488 SCOPUS ID: 2-s2.0-85219421686 02/13/2025

• Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke.

  (Patel RB, Jha AB, Jain A, Verma AK, Saini S, Muia J, Gurung P, Perlman S, Budnik I, Chauhan AK.) Blood Adv. 2025 Mar 25;9(6):1330-1341 PMID: 39787593 PMCID: PMC11950970 SCOPUS ID: 2-s2.0-105000173792 01/09/2025

• Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome.

  (Cataland SR, Coppo P, Scully M, Lämmle B.) Blood. 2024 Sep 12;144(11):1143-1152 PMID: 38958481 SCOPUS ID: 2-s2.0-85199400335 07/03/2024

• Removing cross-cultural barriers to participation in the ISTH Congress.

  (Amigo MC, Mesquita Camelo R, Douketis J, Lee LH, Muia J, Nagao A, Scarlatescu E, Harper AGS.) J Thromb Haemost. 2024 Jul;22(7):1803-1805 PMID: 38849213 SCOPUS ID: 2-s2.0-85195393654 06/08/2024

• Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function.

  (Barton JC, Anderson C, Miranda FZ, Kelley R, Kremer Hovinga JA, Terrell D, Vesely SK, George JN, Muia J.) J Thromb Haemost. 2023 Dec;21(12):3393-3401 PMID: 37633642 PMCID: PMC10840809 SCOPUS ID: 2-s2.0-85171294073 08/27/2023

• Nanoscale organization of CaV2.1 splice isoforms at presynaptic terminals: implications for synaptic vesicle release and synaptic facilitation.

  (Cingolani LA, Thalhammer A, Jaudon F, Muià J, Baj G.) Biol Chem. 2023 Sep 26;404(10):931-937 PMID: 37658578 PMCID: PMC10695435 09/02/2023

• ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.

  (Deconinck SJ, Nix C, Barth S, Bennek-Schöpping E, Rauch A, Schelpe AS, Roose E, Feys HB, Pareyn I, Vandenbulcke A, Muia J, Vandenbriele C, Susen S, Meyns B, Tersteeg C, Jacobs S, De Meyer SF, Vanhoorelbeke K.) J Thromb Haemost. 2022 Dec;20(12):2797-2809 PMID: 36128768 PMCID: PMC9669188 SCOPUS ID: 2-s2.0-85139957186 09/22/2022